Spring Bank Signs a Research Agreement with the University of Texas Southwestern Medical School to Evaluate STING Antagonist Compounds
Shots:
- Spring Bank enters into a collaboration with the University of Texas Southwestern Medical Center for the evaluation of Spring Bank’s STimulator of INterferon Gene (STING) antagonist compounds in autoimmune disease models
- Spring Bank will evaluate novel STING antagonist compounds in mouse models of autoimmune and inflammatory diseases to meet the unmet medical need for the diseases in which cGAS-STING pathway is dysregulated
- Spring Bank’s STING antagonist compounds are designed to block aberrant STING-dependent signaling via a novel mechanism of action and being developed for autoimmune diseases including multiple interferonopathies
Click here to read full press release/ article | Ref: Spring Bank | Image: Market Beat
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com
